Sign up to save your podcasts
Or
Share JAMA Oncology : Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : Five-Year Survival Among Patients With Advanced Skin, Renal, and Lung Cancer Treated With Nivolumab
Interview with Suzanne L. Topalian, author of Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Suzanne L. Topalian, author of Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab
More shows like JAMA Network
View all
Science Magazine Podcast
807 Listeners
JAMA Editors' Summary
129 Listeners
HBR IdeaCast
1,858 Listeners
NEJM This Week
317 Listeners
JAMA Author Interviews
163 Listeners
JAMA Clinical Reviews
486 Listeners
AFP: American Family Physician Podcast
685 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
Frankly Speaking About Family Medicine
255 Listeners
The Curbsiders Internal Medicine Podcast
3,332 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Psychiatry Author Interviews
23 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
85 Listeners
The Indicator from Planet Money
9,532 Listeners
Annals On Call Podcast
181 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Cardionerds: A Cardiology Podcast
408 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
19 Listeners
AMA Update
99 Listeners
NEJM AI Grand Rounds
50 Listeners